Local Institution - 101

Boston, Massachusetts 02215

1 studies enrolling now · 4 studies all time

What they study most

Autoimmune Hemolytic Anemia, Chronic Immune Thrombocytopenia, Leukemia, Myeloid, Acute, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes

Studies at this site

• Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE) — Starting soon
• A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL) — Running, not enrolling
• Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes — Stopped early
• A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) — Running, not enrolling